Clinical Trial Update: Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial is recruiting to evaluate targeted reversal of inflammation in pediatric sepsis-induced MODS. Sponsor: Nationwide Children's Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome
• Sepsis

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS) | Phase 2, Phase 3 | Status: RECRUITING